FR2484253A1 - Comprime de theophylline a liberation prolongee - Google Patents

Comprime de theophylline a liberation prolongee Download PDF

Info

Publication number
FR2484253A1
FR2484253A1 FR8108705A FR8108705A FR2484253A1 FR 2484253 A1 FR2484253 A1 FR 2484253A1 FR 8108705 A FR8108705 A FR 8108705A FR 8108705 A FR8108705 A FR 8108705A FR 2484253 A1 FR2484253 A1 FR 2484253A1
Authority
FR
France
Prior art keywords
theophylline
tablet
tablets
weight
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8108705A
Other languages
English (en)
French (fr)
Other versions
FR2484253B1 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2484253A1 publication Critical patent/FR2484253A1/fr
Application granted granted Critical
Publication of FR2484253B1 publication Critical patent/FR2484253B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8108705A 1980-05-06 1981-04-30 Comprime de theophylline a liberation prolongee Granted FR2484253A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14742980A 1980-05-06 1980-05-06
US24978781A 1981-04-01 1981-04-01

Publications (2)

Publication Number Publication Date
FR2484253A1 true FR2484253A1 (fr) 1981-12-18
FR2484253B1 FR2484253B1 (enrdf_load_stackoverflow) 1983-06-03

Family

ID=26844921

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8108705A Granted FR2484253A1 (fr) 1980-05-06 1981-04-30 Comprime de theophylline a liberation prolongee

Country Status (17)

Country Link
AT (1) AT380789B (enrdf_load_stackoverflow)
AU (1) AU549299B2 (enrdf_load_stackoverflow)
CA (1) CA1165241A (enrdf_load_stackoverflow)
CY (1) CY1368A (enrdf_load_stackoverflow)
DE (1) DE3117756A1 (enrdf_load_stackoverflow)
DK (1) DK155976C (enrdf_load_stackoverflow)
FI (1) FI811356A7 (enrdf_load_stackoverflow)
FR (1) FR2484253A1 (enrdf_load_stackoverflow)
GB (1) GB2078518B (enrdf_load_stackoverflow)
HK (1) HK4288A (enrdf_load_stackoverflow)
IE (1) IE51157B1 (enrdf_load_stackoverflow)
IT (1) IT1209867B (enrdf_load_stackoverflow)
KE (1) KE3722A (enrdf_load_stackoverflow)
LU (1) LU83342A1 (enrdf_load_stackoverflow)
NL (1) NL8102168A (enrdf_load_stackoverflow)
SE (1) SE452550B (enrdf_load_stackoverflow)
SG (1) SG30987G (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002843A1 (en) * 1983-01-26 1984-08-02 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
FR2595945B1 (fr) * 1986-03-19 1990-01-19 Doms Laboratoires Comprime-retard de theophylline a base de p.v.c., et son procede de preparation
USD557612S1 (en) * 2006-04-10 2007-12-18 Parfums Christian Dior Flask for a cosmetic product

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB935601A (en) * 1961-01-31 1963-08-28 Key Pharma Delayed release preparations for asthma therapy containing theophylline
BE663600A (enrdf_load_stackoverflow) * 1964-05-09 1965-11-08
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB935601A (en) * 1961-01-31 1963-08-28 Key Pharma Delayed release preparations for asthma therapy containing theophylline
BE663600A (enrdf_load_stackoverflow) * 1964-05-09 1965-11-08
US3424842A (en) * 1964-05-09 1969-01-28 Merck Ag E Manufacture of tablets directly from dry powders
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002843A1 (en) * 1983-01-26 1984-08-02 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content
GB2143734A (en) * 1983-01-26 1985-02-20 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content

Also Published As

Publication number Publication date
SE8102814L (sv) 1981-11-07
DK200181A (da) 1981-11-07
FI811356L (fi) 1981-11-07
NL8102168A (nl) 1981-12-01
SE452550B (sv) 1987-12-07
DE3117756A1 (de) 1982-04-29
DK155976B (da) 1989-06-12
KE3722A (en) 1987-04-30
LU83342A1 (fr) 1982-01-20
DK155976C (da) 1989-10-30
SG30987G (en) 1987-07-17
IE51157B1 (en) 1986-10-15
GB2078518A (en) 1982-01-13
FR2484253B1 (enrdf_load_stackoverflow) 1983-06-03
CA1165241A (en) 1984-04-10
HK4288A (en) 1988-01-29
GB2078518B (en) 1984-04-11
AU7020581A (en) 1981-11-12
FI811356A7 (fi) 1981-11-07
IT8148406A0 (it) 1981-05-06
IE810989L (en) 1981-11-06
CY1368A (en) 1987-08-07
AT380789B (de) 1986-07-10
AU549299B2 (en) 1986-01-23
ATA202081A (de) 1985-12-15
IT1209867B (it) 1989-08-30
DE3117756C2 (enrdf_load_stackoverflow) 1992-11-26

Similar Documents

Publication Publication Date Title
EP0548356B1 (fr) Comprime multiparticulaire a delitement rapide
EP3115041B1 (fr) Comprimés résistant à l'écrasement destinés à éviter le mésusage involontaire et le détournement illicite
EP1273293B1 (fr) Suspension de fénofibrate dans une solution de polymère hydrophile
BE904899A (fr) Compositions therapeutiques flottantes a degagement progressif.
EP2605757B1 (fr) Formulations a base de nalbuphine et leurs utilisations
FR2547498A1 (fr) Comprimes de naproxen et de naproxen sodique a liberation controlee
FR2523845A1 (fr) Preparations therapeutiques a liberation prolongee a base d'hydroxypropylmethylcellulose de poids moleculaire eleve
FR2797587A1 (fr) Nouvelle composition pharmaceutique
CA2528249A1 (fr) Comprime orodispersible multicouche
BE1000661A4 (fr) Nouvelles compositions pharmaceutiques a base de ketotifene.
WO2004032942A1 (fr) Formulation orale seche a visee phlebotonique et vasculoprotectrice pour le traitement de l'insuffisance veineuse, de la fragilite capillaire et de la crise hemorroidaire, sous forme pharmaceutique de comprime a croquer contenant de la diosmine
BE897221A (fr) Produits a effet prolonge contenant du suloctidil
FR2484253A1 (fr) Comprime de theophylline a liberation prolongee
WO2010015754A1 (fr) Composition pharmaceutique sous forme de granules et procede de fabrication d'une telle composition pharmaceutique
EP2931257B1 (fr) Comprimes orodispersibles obtenus par compression moulage
BE888697A (fr) Comprime de theophylline a liberation prolongee
EP0910341B1 (fr) Composition pharmaceutique destinee a une administration par voie buccale
VARSHNEY et al. Fast dissolving tablet: An Opportunity for treatment of Epilepsy.
Patil et al. REVIEW ARTICLE ON" MEDICATED LOLLIPOP".
BE839604A (fr) Composition a activite retardee
FR2493146A1 (fr) Melange de cromoglycate de sodium avec un excipient hydrosoluble et procede pour sa preparation pour traiter les affections du tractus gastro-intestinal
WO2014185761A1 (fr) Nouvelle composition du 3,4-diaminopyridine pour le traitement de la fatigabilite musculaire associee a des troubles neurovegetatifs
FR2570603A1 (fr) Pastille pharmaceutique de theophylline a liberation prolongee et son procede de preparation
Alejandro et al. FORMULATION OF AN ORALLY FAST-DISSOLVING FILM USING DIPHENHYDRAMINE HYDROCHLORIDE AS THE MODEL DRUG BY SOLVENT CASTING METHOD
FR3095762A1 (fr) Composition solide à ingestion rapide et déglutition facilitée, sous forme de particules solides non agglomérées, comprenant deux différents types de particules

Legal Events

Date Code Title Description
ER Errata listed in the french official journal (bopi)